NEW YORK (GenomeWeb News) – The US Centers for Disease Control and Prevention has licensed DNAStar’s sequence analysis software for use at several of its facilities, the bioinformatics company said today.
The multi-site license agreement allows the CDC’s Coordinating Center for Infectious Disease to use the company’s Lasergene software at its Atlanta base and at its campuses in Colorado, Alaska, and in Puerto Rico.
The Lasergene software includes assembly, visualization, and analysis tools for traditional and next-generation sequencing data, DNAStar said.
The CCID includes the National Center for Immunization and Respiratory Disease; the National Center for Zoonotic, Vector Borne and Enteric Disease; the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention; and the National Center for Preparedness, Control and Prevention of Infectious Diseases.
Financial terms of the agreement were not released.